Literature DB >> 8422701

Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines.

V L Morris1, A B Tuck, S M Wilson, D Percy, A F Chambers.   

Abstract

We have examined tumor progression and metastatic properties of three clonal murine mammary tumor cell lines of recent origin (D2A1, D2.OR and D2.1). These lines were derived from spontaneous mammary tumors which originated from a D2 hyperplastic alveolar nodule (HAN) line. D2A1 cells were more malignant than D2.OR or D2.1 cells, whether measured by experimental metastasis assays after intravenous injection in nude mice or chick embryos, in vivo growth rate of primary tumors following mammary fat pad injection in nude mice, or spontaneous metastasis assay from primary tumors growing in mammary fat pads. D2A1 cells also were more invasive in vitro in a Matrigel invasion assay than D2.1 cells, while the D2.OR cells were non-invasive in this assay. The increased invasiveness and malignancy of D2A1 cells were associated with increased levels of mRNA for the cysteine proteinase cathepsin L. Levels of osteopontin (OPN), nm23, int-1 and int-2 mRNAs were also examined. Nm23 levels were highest in the most malignant cell line. These cell lines provide a model for studying the tumorigenic and metastatic ability of mammary tumor cells and offer several advantages: they were cloned from mammary tumors that originate from a common source of preneoplastic cells (D2HAN); they are of relatively recent origin; and they have spontaneously arrived at different stages of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422701     DOI: 10.1007/bf00880071

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Cytochemical studies of hyperplastic alveolar nodules in the mammary gland of the C3H/He CRGL mouse.

Authors:  M N HARKNESS; H A BERN; M ALFERT; N O GOLDSTEIN
Journal:  J Natl Cancer Inst       Date:  1957-12       Impact factor: 13.506

2.  Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.

Authors:  A F Chambers; R Colella; D T Denhardt; S M Wilson
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

3.  Number and organization of actin-related sequences in the mouse genome.

Authors:  A J Minty; S Alonso; J L Guénet; M E Buckingham
Journal:  J Mol Biol       Date:  1983-06-15       Impact factor: 5.469

4.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.

Authors:  C Waghorne; R S Kerbel; M L Breitman
Journal:  Oncogene       Date:  1987-05       Impact factor: 9.867

6.  Different patterns of gene expression in ras-resistant and ras-sensitive cells.

Authors:  A B Tuck; S M Wilson; R Khokha; A F Chambers
Journal:  J Natl Cancer Inst       Date:  1991-04-03       Impact factor: 13.506

7.  Metastasizing potentials of mouse mammary tumors and their metastases.

Authors:  J Vaage
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

8.  Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones.

Authors:  M P Mark; C W Prince; T Oosawa; S Gay; A L Bronckers; W T Butler
Journal:  J Histochem Cytochem       Date:  1987-07       Impact factor: 2.479

9.  A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.

Authors:  D R Senger; B B Asch; B D Smith; C A Perruzzi; H F Dvorak
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

10.  Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy.

Authors:  P Waterhouse; R S Parhar; X Guo; P K Lala; D T Denhardt
Journal:  Mol Reprod Dev       Date:  1992-08       Impact factor: 2.609

View more
  38 in total

Review 1.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

2.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Authors:  Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg
Journal:  Cancer Discov       Date:  2016-04-12       Impact factor: 39.397

3.  Syndecan-Mediated Ligation of ECM Proteins Triggers Proliferative Arrest of Disseminated Tumor Cells.

Authors:  Tsukasa Shibue; Ferenc Reinhardt; Robert A Weinberg
Journal:  Cancer Res       Date:  2019-09-03       Impact factor: 12.701

4.  The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.

Authors:  Desmond J Tobin; Kerstin Foitzik; Thomas Reinheckel; Lars Mecklenburg; Vladimir A Botchkarev; Christoph Peters; Ralf Paus
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.

Authors:  Holly A Martinson; Sonali Jindal; Clarissa Durand-Rougely; Virginia F Borges; Pepper Schedin
Journal:  Int J Cancer       Date:  2014-09-15       Impact factor: 7.396

6.  Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

Authors:  Marianne M Stanford; Mae Shaban; John W Barrett; Steven J Werden; Philippe-Alexandre Gilbert; Joe Bondy-Denomy; Lisa Mackenzie; Kevin C Graham; Ann F Chambers; Grant McFadden
Journal:  Mol Ther       Date:  2007-11-13       Impact factor: 11.454

7.  Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.

Authors:  Dalit Barkan; Hynda Kleinman; Justin L Simmons; Holly Asmussen; Anil K Kamaraju; Mark J Hoenorhoff; Zi-yao Liu; Sylvain V Costes; Edward H Cho; Stephen Lockett; Chand Khanna; Ann F Chambers; Jeffrey E Green
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 8.  Steps in tumor metastasis: new concepts from intravital videomicroscopy.

Authors:  A F Chambers; I C MacDonald; E E Schmidt; S Koop; V L Morris; R Khokha; A C Groom
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

9.  Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade.

Authors:  Saeed S Akhand; Zian Liu; Stephen C Purdy; Ammara Abdullah; Hang Lin; Gregory M Cresswell; Timothy L Ratliff; Michael Wendt
Journal:  Cancer Immunol Res       Date:  2020-10-22       Impact factor: 11.151

Review 10.  The Relationship Between Dormant Cancer Cells and Their Microenvironment.

Authors:  N Linde; G Fluegen; J A Aguirre-Ghiso
Journal:  Adv Cancer Res       Date:  2016-08-25       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.